The experience of a sample of Canadian men with breast cancer

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 10549-10549
Author(s):  
E. N. Pituskin ◽  
B. Williams ◽  
K. Martin-Mcdonald ◽  
H. Au

10549 Background: Breast cancer is the most frequently diagnosed malignancy among North American women, accounting for about 30% of all new cases each year. Although male breast cancer accounts for less than 1% of all breast cancer cases, recent reports indicate significantly increasing incidence. Research suggests that men diagnosed with breast cancer experience serious psychologic issues including feeling less masculine by having a woman’s disease, feeling isolated with a rare malignancy and feeling uncomfortable seeking or receiving support. Men may also experience post-surgical effects including changed appearance of the male chest and decreased arm strength. There have been numerous large-scale studies examining womens’ experiences with breast cancer. To date, there have been no North American studies examining what a man experiences with a breast cancer diagnosis. The objective of this qualitative study was to determine the experiences of a sample of Canadian men diagnosed with breast cancer. Methods: After ethics approval, an invitation letter and consent form were mailed to those individuals listed as “male”, “breast cancer”, and “alive”, in the Alberta Cancer Registry. 20 men responded indicating their interest. After written consent, audiotaped interviews were conducted. As little is known about a man’s experience with breast cancer, an exploratory qualitative methodology was utilized. Results: We found a great variability among the participants with respect to whom they disclosed their diagnosis, how they viewed their masculinity after a breast cancer diagnosis and their views on life after a cancer experience. All participants stated that there was a major lack of awareness about male breast cancer, both in the public and health professional domain. All participants identified a lack of written information specific for men with breast cancer. All participants denied interest in traditional “support” groups, but would have welcomed the opportunity to speak with a man who had gone through similar diagnosis and treatment. Conclusions: Needs identified by the respondents include increased medical and public awareness of male breast cancer as well as specific written information. Further research is necessary to identify supports and resources helpful for male patients. No significant financial relationships to disclose.

2014 ◽  
Vol 32 (26_suppl) ◽  
pp. 129-129 ◽  
Author(s):  
Raji Shameem ◽  
Muhammad S Hamid ◽  
Gaurang P Mavani ◽  
Nakul Singhal ◽  
Dana Shani ◽  
...  

129 Background: Male Breast Cancer (MBC) survivors have an increased risk of developing secondary contralateral breast cancer. However, the risk of developing other solid tumors and hematological malignancies is not well understood. Methods: The Surveillance Epidemiology and End Results (SEER) database was used to detect MBC cases diagnosed up to 12/31/2011. The Standardized Incidence Ratio (SIR) was calculated as the ratio of observed to expected cases of second primary malignancy based on incidence data in the general United States population. The latency exclusion period from the date of diagnosis was 5 years. We also investigated for any modifying effects such as radiation therapy, age at diagnosis, and latency period after initial diagnosis (5-10 years and >10 years) that may have increased the risk for secondary cancer. Results: A total of 1,239 men with an initial diagnosis of primary breast cancer were included in our analysis. Overall, there was an increased SIR of secondary solid tumors of the pharynx (SIR: 8.39, P<0.05), hypopharynx (SIR: 15.77, P<0.05), and brain (SIR: 4.40, p<0.05), and Non-Hodgkin Lymphoma (NHL) (SIR: 2.49, P<0.05), that was also seen in MBC cases that received radiation (24.1%), (SIR: 4.51, P<0.05). For MBC diagnoses in patients >40 years, there was an increased incidence for these malignancies and for “all solid tumors” (SIR: 1.30, P<0.05) as well. In the period ranging from 5-10 years after initial breast cancer diagnosis increased incidence for tumors of the pharynx (SIR: 8.95, P<0.05) and hypopharynx (SIR: 16.70, P<0.05) were seen. In contrast, there was no significant increased incidence of secondary cancers >10 years after initial diagnosis. Conclusions: MBC survivors are at increased risk for secondary malignancies of the pharynx, hypopharynx, brain, and NHL. Older age at diagnosis and radiation treatment appear to be risk factors. Risk of secondary tumors of the pharynx and hypopharynx is greatest 5-10 years after initial breast cancer diagnosis but optimal surveillance for MBC survivors requires further clarification.


2018 ◽  
Vol 16 (1) ◽  
Author(s):  
Nayi Zongo ◽  
Smaïla Ouédraogo ◽  
Nina Korsaga-Somé ◽  
Ollo Roland Somé ◽  
Naïma GO ◽  
...  

2019 ◽  
Vol 7 ◽  
pp. 232470961984723
Author(s):  
Leila Moosavi ◽  
Phyllis Kim ◽  
An Uche ◽  
Everardo Cobos

In this article, we present a patient diagnosed synchronously with metastatic male breast cancer and prostate cancer. This is a 63-year-old male and recent immigrant from Nigeria, who sought medical attention for progressively worsening of shortness of breath and acute progression of a chronic right breast mass. An invasive breast carcinoma was diagnosed by the core biopsy of the right breast mass. Within 2 months of his breast cancer diagnosis, the patient also was diagnosed with prostate adenocarcinoma after being worked up for urinary retention. By presenting this patient with a synchronous diagnosis with metastatic male breast cancer and prostate cancer, history of chronic right breast mass, and gynecomastia, we speculate on possible cancer etiologies and risk factors.


2016 ◽  
Vol 23 (9) ◽  
pp. 1223-1233 ◽  
Author(s):  
Leonie Lalayiannis ◽  
Nicky Asbury ◽  
Graham Dyson ◽  
Amanda Walshe

This study investigated how women with secondary breast cancer experience telling their adolescent children. Semi-structured interviews were conducted with women who had been diagnosed with secondary breast cancer at least 1 year prior to the interview. Seven women, who had at least one child between 12 and 19 years old living at home at the time of diagnosis, were interviewed. The interviews were analysed using interpretative phenomenological analysis for an in-depth understanding of women’s experiences. Women found that it was easier to tell their children of their secondary breast cancer diagnosis compared to their primary cancer. However, they talked about the impact the diagnosis had on their family.


2016 ◽  
Vol 11 (2) ◽  
pp. 246-252 ◽  
Author(s):  
Sarah Rayne ◽  
Kathryn Schnippel ◽  
John Thomson ◽  
Joanna Reid ◽  
Carol Benn

The purpose of the current study was to describe male breast cancer in Johannesburg, South Africa, and assess whether male breast cancer patients’ perception of their own masculinity was affected by having a cancer commonly seen in women. A retrospective file review was carried out at two hospitals, one private and one government, of male breast cancer patients from 2007 to 2012 followed by a telephone survey of patients identified during review. Of approximately 3,000 breast cancer patients seen in the 5 years reviewed, 23 cases of male breast cancer were identified. Most were diagnosed with invasive ductal carcinoma ( n = 19, 83%). Stage at presentation was from stages 0 to 3 (Stage 0 [ n = 2, 9%], Stage 1 [ n = 3, 13%], Stage 2 [ n = 12, 52%], Stage 3 [ n = 6, 26%]) and no patients were metastatic at presentation. The telephonic survey was completed by 18 patients (78%). Nearly all ( n = 17/18) shared their diagnosis with family and close friends. Two thirds of patients delayed presentation and government hospital patients were more likely to present later than private sector hospital patients. Although most male breast cancer patients sampled did not perceive the breast cancer diagnosis as affecting their masculinity, Black men and those treated in government hospitals were less likely to be aware of male breast cancer, and were more likely to have their perception of their own masculinity affected.


Oncology ◽  
2014 ◽  
Vol 87 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Tal Grenader ◽  
Rinat Yerushalmi ◽  
Margarita Tokar ◽  
Georgeta Fried ◽  
Bella Kaufman ◽  
...  

2007 ◽  
Vol 10 (8) ◽  
Author(s):  
E. D. Rossmann ◽  
A. Liljegren ◽  
J. Bergh

AbstractTreatment principles of breast cancer in males are derived from studies performed among females, while the low incidence in males has so far precluded such studies. The therapy recommendations for males therefore lack the solid evidence, frequently present for females with breast cancer. The primary breast cancer diagnosis in males is not infrequently in stage III/IV and at higher age, thereby requiring multiprofessional and multimodal management including preoperative therapy and adjuvant therapies based on the tumour’s biological characteristics and the clinical circumstances. The majority of male breast cancer tumours are oestrogen-receptor positive and adjuvant/neoadjuvant tamoxifen is therefore recommended, surgery is frequently radical mastectomy and adjuvant radiotherapy should likely be used on wider indications. Chemotherapy should be considered both in the adjuvant and metastatic setting for receptor-negative cancers and for patients with biologically aggressive disease. Trastuzumab should be offered to patients with Her-2/neu-positive disease, while the use of aromatase inhibitors is more uncertain due to differences in the hormonal environment in males.


2021 ◽  
pp. 1-6
Author(s):  
Hiu Tat Kwok ◽  
Minh Van ◽  
Ka Siu Fan ◽  
Jeremy Chan

BACKGROUND: Male breast cancer is a considerably rare condition and only accounts for 1% of all breast cancer cases. Due to limited public awareness, the condition is likely to present late, leading to late diagnosis and treatment worsening morbidity and mortality. This article aims to identify the focus and most influential research on male breast cancer. Objective Identify the most influential papers in male breast cancer. METHODS: Search on Web of Science using the search terms ‘Male’, ‘Breast Cancer’ and “Male breast cancer” to identify all full manuscripts in English language and were ranked by the total number of citations. The top 100 articles were then further analysed according to subject, author, journal, year and country of publications. RESULTS: The mean number of citations per paper was 96. Most cited paper was by Thorlacius, S et al. evaluating the relationship between BRCA2 and female breast cancer, prostate cancer, pancreatic cancer and ovarian cancer. Cancer is the journal with the most published papers and received most citations in the male breast cancer research field. The USA contributed 49 of the manuscripts in the top 100. The most studied topic was risk factors for male breast cancer, with 20 articles. CONCLUSIONS: The most cited papers identified in this study described the advance in the knowledge of genetics and epidemiology in male breast cancer and has led to improvements in the 4 management of the disease. Most of the highly cited articles in this field were published in high impact journals and had accumulated at least 100 citations to date, reflecting their quality and impact. By collating the most influential publications in this field, this analysis can serve to identify knowledge gaps in male breast cancer research as well as to help identify what makes a paper impactful and citable.


Sign in / Sign up

Export Citation Format

Share Document